Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years or over~* Diagnosis = ITP + platelet count above or equal to 25 Mia/l or platelet count above or equal to 50 Mia/l and bleeding from the mucous membranes.~* Adequate contraceptive measures within the last 3 months for women of childbearing potential.~Exclusion Criteria:~* Performance status above or equal to 2~* Previous treatment with rituximab~* Immunosuppressive treatment within the last month except for not previously treated patients~* Other serious disease~* Pregnant women and nursing mothers~* Contraindication for rituximab treatment.~* Active infection requiring antibiotic treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Combination therapy with Dexamethasone and Rituximab
- 2 (Type: ACTIVE_COMPARATOR): Dexamethasone as monotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).